Abstract: Trichinellosis is a cosmopolitan foodborne disease that may result in severe health disorders and even death. Despite international awareness of the public health risk associated with trichinellosis, current data on its public health impact are still lacking. Therefore we assessed, for the first known time, the global burden of trichinellosis using the Disability-Adjusted Life Year metric. The global number of Disability-Adjusted Life Years due to trichinellosis was estimated to be 76 per billion persons per year (95% credible interval: 38-129). The World Health Organization European Region was the main contributor to this global burden, followed by the WHO region of the Americas and the World Health Organization Western Pacific region. The global burden of trichinellosis is much lower than that of other foodborne parasitic diseases and is in sharp contrast to the high budget allocated to prevent the disease in many industrialised countries. To decrease the uncertainty around the current estimates, more knowledge is needed on the level of underreporting of clinical trichinellosis in different parts of the world. 
Introduction
Trichinellosis is a foodborne helminthic disease caused by one of several Trichinella species (Pozio and Zarlenga, 2013) . Infection occurs when humans consume raw or undercooked meat of different animal origins, e.g. pork, horse or game, containing muscle larvae (Gottstein et al., 2009 ). Clinical signs of trichinellosis are various and not pathognomonic, making the diagnosis complicated, which leads to medical misclassification and underreporting. In the acute phase of the disease, infected individuals may present with gastrointestinal disorders such as diarrhoea, but also with myalgia, fever, headache and facial oedema (Pozio et al., 2003) . Whether or not a chronic form of trichinellosis exists is still under debate. The few studies that included follow-up over a longer time span indicated that myalgia and fatigue can persist for four months and, in a substantial proportion of cases, for up to two years (Nemet et al., 2009 ). tested, a gross estimate of the annual cost linked to pig testing in the EU amounts to €220 million (Kapel, 2005) . Other sources report an annual cost of about US$ 570 million in the EU for inspection for Trichinella and US$ 1 billion due to swine and human trichinellosis in the United States, primarily for health regulatory activities to prevent infection (Murrell and Pozio, 2000) .
The aim of the current study is to provide the first global burden of disease assessment for trichinellosis, based on the Disability-Adjusted Life Year (DALY) metric. This assessment is part of a larger exercise of the World Health Organization (WHO) to assess to global burden of all major foodborne diseases ).
Materials and methods

Incidence and mortality
The estimation of the global incidence and mortality of trichinellosis presented here is based on the results of a recent systematic review on the worldwide epidemiology and clinical impact of human trichinellosis between 1986 and 2009 (Murrell and Pozio, 2011) . Searches of six international databases yielded 494 reports, of which 261 were selected for data extraction after applying strict relevance and reliability criteria. From 1986 through 2009, there were 65,818 cases and 42 deaths reported from 41 countries. The apparent annual incidence and mortality of trichinellosis was calculated by dividing the average number of cases and deaths in this 24-year period by the 1997 mid-year population (WHO, 1998). As in Murrell and Pozio (2011), we stratified our incidence and mortality rates by WHO region.
Because of the important variability in the reporting of the disease, the apparent incidence and mortality rates were adjusted to account for underreporting of the cases due to underascertainment, medical misclassification and/or absence of effective surveillance systems. putative trichinellosis cases was based on serology, the estimate of six "true" trichinellosis cases per "apparent" case is likely an overestimation. However, given the scarcity of data on the level of underreporting for trichinellosis, we applied this correction factor to the incidence and mortality rates in the AFRO, EMRO, SEARO and WPRO WHO regions, in order to obtain a plausible upper bound for the true incidence and mortality rates. For the EURO and AMRO WHO regions, where surveillance is likely more efficient, we arbitrarily applied, in the absence of any data, a correction factor of two, implying that for every reported case there is assumed to be a non-reported one.
Disability-Adjusted Life Years
The DALY metric has been developed as an alternative method to estimate, compare and rank the burden of diseases by including both fatal and non-fatal health outcomes. DALYs can be interpreted as the number of healthy life years lost due to a disease, and result from the sum of the number of years lived with a disability (YLDs) due to the disease, and the number of years of life lost due to disease-related mortality (YLLs) (Murray, 1994) . This concept was first used in the Global Burden of Disease (GBD) study, a comprehensive assessment of the worldwide health impact of more than 100 diseases and risk factors. The calculations of the GBD have been or death in years, and a disability weight (DW), expressing the severity of the outcome on a scale from zero to one. The YLLs are calculated as the product of the number of deaths and the standard life expectancy at age of death in years. Instead of absolute numbers, DALYs can also be calculated as rates, expressing e.g. the number of healthy life years lost per 100,000 people per year.
The incidence and mortality rates were estimated as described in section (2.1). To account for the uncertainty in the level of underreporting, we let the regional incidence and mortality rates vary uniformly between their raw and adjusted values. To be able to calculate sex and age stratified DALYs, we further stratified these incidence and mortality rates based on Murrell and Pozio (2011), who found that 51% of cases were male and the majority of cases was between 20 and 50 years of age, with a median of 33.1. A generalized Beta distribution was fitted to the latter estimates to define the full distribution of cases from age 0 to 90.
In absence of data on the probability of occurrence of the major clinical symptoms of acute trichinellosis, we assumed, as a worst case scenario, that all patients would develop diarrhoea, facial oedema, myalgia and fever/headache. Because no specific DW for trichinellosis is Table 1 
Results
Discussion
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